Ionis Pharmaceuticals Inc
F:ISI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Ionis Pharmaceuticals Inc
F:ISI
|
US |
|
Hapbee Technologies Inc
XTSX:HAPB
|
CA |
|
B
|
BP PLC
BMV:BPN
|
UK |
|
Critical Elements Lithium Corp
F:F12
|
CA |
|
R
|
Rewalk Robotics Ltd
F:2RW
|
IL |
|
C
|
Canadian Imperial Bank of Commerce
XMUN:CAI
|
CA |
|
V
|
Verisign Inc
XMUN:VRS
|
US |
|
G
|
Grupo Clarin SA
BCBA:GCLA
|
AR |
|
Philly Shipyard ASA
OSE:PHLY
|
NO |
|
Giftee Inc
TSE:4449
|
JP |
|
F
|
FirstEnergy Corp
SWB:FE7
|
US |
|
Sopra Steria Group SA
PAR:SOP
|
FR |
|
DTE Energy Co
NYSE:DTE
|
US |
|
Bonduelle SA
F:BDU
|
FR |
Shareholder Yield
Current shareholder yield for 
ISI is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ISI Price
Ionis Pharmaceuticals Inc
| Average Annual Return | 4.81% |
| Standard Deviation of Annual Returns | 29.72% |
| Max Drawdown | -39% |
| Market Capitalization | 9.6B EUR |
| Shares Outstanding | 145 970 000 |
| Percentage of Shares Shorted |
N/A
|
